WUXI BIOLOGICS Financials

WUXI BIOLOGICS Stock Summary

WUXI BIOLOGICS competes with Novo Nordisk, CSL, CSL, Mercedes Benz, and Vertex Pharmaceuticals. WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany.

WUXI BIOLOGICS Key Financial Ratios

There are many critical financial ratios that WUXI BIOLOGICS's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that WUXI BIOLOGICS UNSPADR2 reports annually and quarterly.

WUXI Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining WUXI BIOLOGICS's current stock value. Our valuation model uses many indicators to compare WUXI BIOLOGICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WUXI BIOLOGICS competition to find correlations between indicators driving WUXI BIOLOGICS's intrinsic value. More Info.WUXI BIOLOGICS UNSPADR2 is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.45  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WUXI BIOLOGICS UNSPADR2 is roughly  2.23 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WUXI BIOLOGICS's earnings, one of the primary drivers of an investment's value.

WUXI BIOLOGICS UNSPADR2 Systematic Risk

Along with financial statement analysis, the daily predictive indicators of WUXI BIOLOGICS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of WUXI BIOLOGICS UNSPADR2. We use our internally-developed statistical techniques to arrive at the intrinsic value of WUXI BIOLOGICS UNSPADR2 based on widely used predictive technical indicators. In general, we focus on analyzing WUXI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build WUXI BIOLOGICS's daily price indicators and compare them against related drivers.

When running WUXI BIOLOGICS's price analysis, check to measure WUXI BIOLOGICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WUXI BIOLOGICS is operating at the current time. Most of WUXI BIOLOGICS's value examination focuses on studying past and present price action to predict the probability of WUXI BIOLOGICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WUXI BIOLOGICS's price. Additionally, you may evaluate how the addition of WUXI BIOLOGICS to your portfolios can decrease your overall portfolio volatility.